Urinary Tract Infection Treatment Market Growth and Analysis by 2027

[Research Report] The market is expected to reach US$ 11,614.32 million by 2027 from US$ 9,106.40 million in 2019; it is estimated to grow at a CAGR of 3.2% from 2020 to 2027.

The growth of the market is attributed to the growing prevalence of urinary tract infections, aging population, and emerging computing technologies for urine diagnostics. However, the lack of product awareness in emerging countries and effects associated with medication obstruct the growth of the Urinary Tract Infection Treatment market to a certain extent.

Published Report - Urinary Tract Infection Treatment Market: Strategic Insights

Market Insights

Growing Incidence of Urinary Tract Infections

Women are at a higher risk of developing urinary tract infections (UTIs) than men. UTIs, if go untreated, can lead to severe pain along with serious consequences to kidneys. UTIs show certain symptoms such as persistent urge to urinate, inflammation, change in appearance of urine, and nausea. The increasing prevalence of UTIs is one of the prominent factors driving the growth of the urinary tract infection treatment market. For instance, according to a study conducted by a group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020, UTIs accounts for ~6 million physicians visits each year in the US.

Certain risk factors such as sexual activity, poor hygiene, and aging may cause UTIs. Increasing incidence of these risk factors are also estimated to drive the urinary tract infection treatment market growth by 2027. According to a study published in the International Journal of Environmental Research and Public Health in 2019, patients with existing chronic conditions such as coronary artery disease (CAD), chronic kidney disease (CKD), and diabetes mellitus (DM) have high possibilities of acquiring UTIs. Therefore, the high epidemiology of UTI generates demand for its treatment products, eventually driving the market growth.

Drug Class-Based Insights

Based on drug class, the quinolones segment held the largest share of the market in 2019; however, the penicillin and combination segment is anticipated to register the highest CAGR of 4.5% in the market during the forecast period. The future growth of the market for quinolones is mainly ascribed to the fact that it is most commonly prescribed by physicians. Ciprofloxacin, levofloxacin, and enoxacin are among the most widely used drugs for treatment..

Indication-Based Insights

The urinary tract infection treatment market, by indication, is segmented into complicated urinary tract infections and uncomplicated urinary tract infections. The complicated urinary tract infections segment held a larger market share in 2019; also, the segment is anticipated to register a higher CAGR in the market during the forecast period.

Distribution Channel-Based Insights

The urinary tract infection treatment market, by distribution channel, is segmented into hospital pharmacies, gynecology and urology clinics, drug stores, retail pharmacies, and online drug stores. The hospital pharmacies distribution channel segment held the largest share of the market in 2019, whereas online drug stores segment is anticipated to register the highest CAGR in the market during the forecast period.

The urinary tract infection treatment market players—such as Shionogi & Co., Ltd.; Teva Pharmaceutical Industries Ltd;  Allergan; and Pfizer—have been adopting several organic and inorganic strategies to enhance their revenue and market standings. For instance, in April 2019, Teva Pharmaceutical Industries Ltd announced the launch of a generic version of VESIcare (solifenacin succinate) Tablets, 5 mg and 10 mg, in the US.

Urinary Tract Infection Treatment

Published Report - Urinary Tract Infection Treatment Market Regional Insights

The regional trends and factors influencing the Published Report - Urinary Tract Infection Treatment Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Published Report - Urinary Tract Infection Treatment Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Published Report - Urinary Tract Infection Treatment Market Report Scope

Published Report - Urinary Tract Infection Treatment Market Players Density: Understanding Its Impact on Business Dynamics

The Published Report - Urinary Tract Infection Treatment Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Urinary Tract Infection Treatment Market– by Drug Class

• Penicillin and Combinations
• Quinolones
• Cephalosporin
• Aminoglycoside Antibiotics
• Sulphonamides
• Nutritional Supplements

Urinary Tract Infection Treatment Market– by Indication

• Complicated Urinary Tract Infection
• Uncomplicated Urinary Tract Infection

Urinary Tract Infection Treatment Market– by Distribution Channel

• Hospital Pharmacies
• Gynaecology and Urology Clinics
• Retail Pharmacies and Drug Store
• Online Drug Stores

Urinary Tract Infection Treatment Market – by Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East &Africa
• South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

• Teva Pharmaceutical Industries Ltd
• Sun Pharmaceutical Industries Ltd
• Mylan N.V.
• ALLERGAN
• Pfizer Inc.
• Cipla Ltd
• F. Hoffmann-La Roche Ltd
• Shionogi Inc.
• Amway
• DuPont Nutrition & Biosciences